Atosiban versus placebo in the treatment of threatened preterm birth between 30 and 34 weeks gestation: study protocol of the 4-year APOSTEL 8 follow-up

Atosiban versus placebo in the treatment of threatened preterm birth between 30 and 34 weeks gestation: study protocol of the 4-year APOSTEL 8 follow-up

Introduction Currently, the majority of women worldwide with threatened preterm birth are treated with tocolytics. Although tocolytics can effectively delay birth for 48 hours, no tocolytic drug has convincingly been shown to improve neonatal outcomes and effects on long-term child development are u...

Full description

Bibliographic Details
Main Authors: Martijn A Oudijk, Madelon van Wely, Eva Pajkrt, Job Klumper, Aleid G van Wassenaer-Leemhuis, Emilie V J van Limburg Stirum, Janneke Van 't Hooft, Larissa van der Windt
Format: Article
Language:English
Published: BMJ Publishing Group 2024-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/7/e083600.full

Internet

https://bmjopen.bmj.com/content/14/7/e083600.full

Similar Items